Methods for the treatment of thyroid eye disease with anti-IGF-1R antagonist antibodies
CL202601939A1Pending Publication Date: 2026-07-10HORIZON THERAPEUTICS IRELAND DAC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CL202601939
- Authority / Receiving Office
- CL · CL
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-12
- Filing Date
- 2026-06-11
- Publication Date
- 2026-07-10
Abstract
This document describes methods for treating or reducing the severity of thyroid eye disease (TED), as well as antibodies that bind to and inhibit signaling through the insulin-like growth factor receptor 1, useful in these methods.
Need to check novelty before this filing date? Find Prior Art